{"id": "1342112066623062016", "creation": 1608819426.0, "user_id": "1181166787490021377", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 1, "like_count": 12, "quote_count": 0}}, "text": "India's Zydus Cadila plans Phase III trials of COVID-19 vaccine in around 30,000 volunteers, post approval. ZyCoV-D was safe, well tolerated and immunogenic in the Phase I/II clinical trials says company #COVID19 #Covid #vaccine", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#COVID", "#VACCINE"]}